Construction is complete on the Samuel Oschin Air & Space Center in Exposition Park. The new 20-story wing will display the shuttle Endeavour vertically and nearly double exhibit space.

Penn and Temple pulled in three of the nation's top gifts in 2025, including a $120M donation to Penn Medicine and a record $55M gift to Temple's public‑health college.

Cayo, a 10-foot juvenile great white, pinged off Palm Beach on April 13 as researchers continue to track her long coastal migration.

A new analysis shows Penn’s federal receipts fell to $948M in FY2025, prompting a hiring freeze and 4% spending cuts as leaders brace for more federal policy churn.

Voyager Technologies says its Littleton plant has doubled propulsion output and now assembles roughly one module a day after acquiring ExoTerra. The move expanded the site and added about 200 jobs.

Case Western Reserve landed a $3.1M NICHD grant to test three ways to restore touch in people with quadriplegia. The trial will use volunteers already implanted with electrodes.

The University of Utah has proposed an on‑campus Olympics research center to study sustainability, athlete wellbeing and legacy work as Utah eyes the 2034 Winter Games. The move expands ongoing partnerships and taps local economic research.

A Salk‑led consortium won an ARPA‑H award of about $41.3M to push sonogenetics — engineered ultrasound‑sensitive proteins plus wearable devices — toward early clinical tests.

West‑MEC opened what it bills as the nation's first K–12 semiconductor cleanroom at its Northeast Campus, aiming to give students industry‑grade training for chip jobs. The new space pairs cleanroom protocol training with robotics and certification pathways.

A Laurel STEM university is expanding flight training and new aviation degrees after a 44% enrollment surge. The push uses FAA pathways and regional airports to grow enrollment.

Gallup’s latest workforce poll finds rising AI adoption, but about half of U.S. employees use AI only rarely or not at all, citing ethics, privacy and job concerns.

Seaport Therapeutics filed to go public, aiming to raise roughly $100M to advance its Glyph neuropsychiatry pipeline.

Ben Lamm says gene drives can curb a $5.4 trillion invasive‑species problem; safety and regulatory questions remain. The pitch puts Dallas biotech at the center of a fraught debate.